Bellevue Group AG Q4 2024 Filing
Filed February 14, 2025
Portfolio Value
$5.2B
Holdings
161
Report Date
Q4 2024
Filing Type
13F-HR
All Holdings (161 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | SPYSPDR S&P 500 ETF TR | 5,660 | $3.3B | 63.85% | |
| 102 | SMMTSUMMIT THERAPEUTICS INC | 170,594 | $3.0B | 58.60% | |
| 103 | BTSGBRIGHTSPRING HEALTH SVCS INC | 174,152 | $3.0B | 57.09% | |
| 104 | CAHCARDINAL HEALTH INC | 22,298 | $2.6B | 50.76% | |
| 105 | RXRXRECURSION PHARMACEUTICALS IN | 377,806 | $2.6B | 49.16% | |
| 106 | AZNASTRAZENECA PLC | 35,700 | $2.3B | 45.02% | |
| 107 | BMYBRISTOL-MYERS SQUIBB CO | 38,113 | $2.2B | 41.49% | |
| 108 | ACCDEURACCOLADE INC | 615,509 | $2.1B | 40.52% | |
| 109 | ZTSZOETIS INC | 9,779 | $1.6B | 30.67% | |
| 110 | RDYDR REDDYS LABS LTD | 97,900 | $1.5B | 29.76% | |
| 111 | DOCSDOXIMITY INC | 27,911 | $1.5B | 28.68% | |
| 112 | TEVATEVA PHARMACEUTICAL INDS LTD | 60,598 | $1.3B | 25.71% | |
| 113 | RYTMRHYTHM PHARMACEUTICALS INC | 23,596 | $1.3B | 25.43% | |
| 114 | GOOGALPHABET INC | 6,000 | $1.1B | 21.99% | |
| 115 | PCVXVAXCYTE INC | 12,038 | $985.4M | 18.97% | |
| 116 | CERTCERTARA INC | 92,129 | $981.2M | 18.89% | |
| 117 | CVSCVS HEALTH CORP | 21,844 | $980.6M | 18.88% | |
| 118 | BNTXBIONTECH SE | 8,332 | $949.4M | 18.28% | |
| 119 | PTGXPROTAGONIST THERAPEUTICS INC | 23,718 | $915.5M | 17.62% | |
| 120 | GDXVANECK ETF TRUST | 26,200 | $888.4M | 17.10% | |
| 121 | AMRXAMNEAL PHARMACEUTICALS INC | 100,414 | $795.3M | 15.31% | |
| 122 | KRYSKRYSTAL BIOTECH INC | 5,047 | $790.7M | 15.22% | |
| 123 | NAMSNEWAMSTERDAM PHARMA COMPANY | 25,000 | $642.5M | 12.37% | |
| 124 | ARQTARCUTIS BIOTHERAPEUTICS INC | 39,500 | $550.2M | 10.59% | |
| 125 | VKTXVIKING THERAPEUTICS INC | 12,939 | $520.7M | 10.02% | |
| 126 | CYTKCYTOKINETICS INC | 10,941 | $514.7M | 9.91% | |
| 127 | BIIBBIOGEN INC | 2,652 | $405.5M | 7.81% | |
| 128 | TVTXTRAVERE THERAPEUTICS INC | 23,100 | $402.4M | 7.75% | |
| 129 | QUREUNIQURE NV | 22,500 | $397.4M | 7.65% | |
| 130 | ASNDASCENDIS PHARMA A/S | 2,500 | $344.2M | 6.63% | |
| 131 | ZLABZAI LAB LTD | 13,000 | $340.5M | 6.55% | |
| 132 | MDGLMADRIGAL PHARMACEUTICALS INC | 1,100 | $339.4M | 6.53% | |
| 133 | MRUSMERUS N V | 8,000 | $336.4M | 6.48% | |
| 134 | XENEXENON PHARMACEUTICALS INC | 8,200 | $321.4M | 6.19% | |
| 135 | DNLIDENALI THERAPEUTICS INC | 15,700 | $320.0M | 6.16% | |
| 136 | ADMAADMA BIOLOGICS INC | 16,900 | $289.8M | 5.58% | |
| 137 | BBIOBRIDGEBIO PHARMA INC | 10,400 | $285.4M | 5.49% | |
| 138 | ROIVROIVANT SCIENCES LTD | 24,000 | $283.9M | 5.47% | |
| 139 | 2L9BLUEPRINT MEDICINES CORP | 3,200 | $279.1M | 5.37% | |
| 140 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 4,400 | $238.3M | 4.59% | |
| 141 | ACLXARCELLX INC | 3,000 | $230.1M | 4.43% | |
| 142 | GRMNGARMIN LTD | 1,050 | $216.6M | 4.17% | |
| 143 | MLYSMINERALYS THERAPEUTICS INC | 16,499 | $203.1M | 3.91% | |
| 144 | PTCTPTC THERAPEUTICS INC | 3,800 | $171.5M | 3.30% | |
| 145 | OCSOCULIS HOLDING AG | 10,000 | $170.0M | 3.27% | |
| 146 | BIDUNBAIDU INC | 2,000 | $168.6M | 3.25% | |
| 147 | RAREULTRAGENYX PHARMACEUTICAL IN | 4,000 | $168.3M | 3.24% | |
| 148 | KNSAKINIKSA PHARMACEUTICALS INTL | 8,100 | $160.2M | 3.08% | |
| 149 | NRIXNURIX THERAPEUTICS INC | 8,000 | $150.7M | 2.90% | |
| 150 | VCYTVERACYTE INC | 3,600 | $142.6M | 2.74% | |
| 151 | KURAKURA ONCOLOGY INC | 13,600 | $118.5M | 2.28% | |
| 152 | MRNAMODERNA INC | 150 | $110.0M | 2.12% | Call |
| 153 | ORCLORACLE CORP | 654 | $109.0M | 2.10% | |
| 154 | AG8AGILENT TECHNOLOGIES INC | 806 | $108.3M | 2.08% | |
| 155 | NVDANVIDIA CORPORATION | 751 | $100.9M | 1.94% | |
| 156 | AUTLAUTOLUS THERAPEUTICS PLC | 41,500 | $97.5M | 1.88% | |
| 157 | MSFTMICROSOFT CORP | 203 | $85.6M | 1.65% | |
| 158 | QCOMQUALCOMM INC | 447 | $68.7M | 1.32% | |
| 159 | MTDMETTLER TOLEDO INTERNATIONAL | 42 | $51.4M | 0.99% | |
| 160 | LHLABCORP HOLDINGS INC | 216 | $49.5M | 0.95% | |
| 161 | TEMTEMPUS AI INC | 237 | $8.0M | 0.15% |
PreviousPage 2 of 2